Amar Remedies IPO vs Aurionpro Solutions IPO

Comparison between Amar Remedies IPO and Aurionpro Solutions IPO.

IPO Details

Amar Remedies IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Aurionpro Solutions IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Amar Remedies IPO is whereas the issue size of the Aurionpro Solutions IPO is . The final issue price of Amar Remedies IPO is ₹28.00 per share and of Aurionpro Solutions IPO is ₹90.00 per share.

 Amar Remedies IPOAurionpro Solutions IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹24.00 per share₹81.00 per share
Issue Price (Upper)₹28.00 per share₹90.00 per share
Issue Price (Final)₹28.00 per share₹90.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size
Fresh Issue Size1,50,00,000 shares30,00,000 shares
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total1,50,00,000 shares30,00,000 shares
Issue Size Total (Amount)

IPO Timetable

Amar Remedies IPO opens on Aug 25, 2005, while Aurionpro Solutions IPO opens on Sep 27, 2005. The closing date of Amar Remedies IPO and Aurionpro Solutions IPO is Aug 31, 2005, and Oct 04, 2005, respectively.

Financials & KPIs

Amar Remedies IPO P/E ratio is , as compared to Aurionpro Solutions IPO P/E ratio of .

Shares Offered

In the Amar Remedies IPO Retail Individual Investors (RII) are offered 52,50,000 shares while in Aurionpro Solutions IPO retail investors are offered 52,50,000 shares. Qualified Institutional Buyers (QIB) are offered 75,00,000 shares in Amar Remedies IPO and 13,75,000 shares in Aurionpro Solutions IPO.

 Amar Remedies IPOAurionpro Solutions IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation
QIB75,00,000 shares13,75,000 shares
NII22,50,000 shares4,12,500 shares
RII52,50,000 shares9,62,500 shares
Employee2,50,000 shares
Others
Total1,50,00,000 shares30,00,000 shares

Bids Received (Subscription)

Amar Remedies IPO subscribed in total, whereas Aurionpro Solutions IPO subscribed .

Compare with others

Compare: